VirusGEN® AAV Transfection Kits with RevIT™ AAV Enhancer

Supplier: Mirus Bio
VirusGEN® AAV RevIT™ AAV
MIR8008 MIR8006 MIR8080 MIR8000 MIR8007
77119-150EA 9513.68 USD
77119-150 77119-146 77119-144 77394-770 77119-148
VirusGEN® AAV Transfection Kits with RevIT™ AAV Enhancer
Transfection Reagents
This novel enhancer is easily integrated into existing workflows, and it produces 2-4x higher titers across a range of serotypes, cellular growth media formulations, and transfection platforms. RevIT™ AAV Enhancer can further drive down upstream manufacturing costs by permitting the use of lower levels of plasmid DNA while maintaining high-quality titers. Continual improvements in both upstream and downstream AAV manufacturing processes will allow the next generation of gene therapies to reach a broader audience

  • Designed to deliver a higher titer for any serotype, reagent, media, or cell line.
  • 2-4X increase in AAV titer.
  • >50% reduction in cost per dose.
  • 2X doses produced per bioreactor run.
Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Learn more About VWR